(Q45419071)

English

EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation

scientific article published in May 2013

Statements

EASL and mRECIST responses are independent predictors of survival in hepatocellular carcinoma patients treated with cryoablation (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit